All In Biotech

Drug Trial Radar · NCT06951802

Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine

Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine A Single-Centre, Prospective, Randomized, Controlled Trial

Last checked: Nov 20, 2026Latest source record: Apr 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 118 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

118

Planned (sponsor's estimate)

Start

Dec 3, 2024

Primary completion

Jun 30, 2025

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Insel Gruppe AG, University Hospital BernAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 30, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RCT comparing intraoperative administration of low-dose ketamine during laparoscopic endometriosis operation and the postoperative pain outcome

Conditions

  • Endometriosis

Interventions

  • KetamineDrug

    Low-dose administration of ketamine during laparoscopic surgery

  • PropofolDrug

    Control group

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total opioids prescribed and consumed during hospitalization for endometriosis.Time frame: During hospitalisation, expected to be on average 2-5 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Inselspital Bern

    Bern, Switzerland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.